Latka logo

AI Medical Systems revenue, team size, customer count, churn, and more in 2026.

AI Medical is a technology-led company, focused solely on the design and manufacture of dependable, life improving Artificial Intelligence and machine learning software coupled with robotic hardware that are affordable for caregivers worldwide.

AI Medical Systems Revenue

We do not have information about AI Medical Systems's revenue yet.

AI Medical Systems Valuation, Funding Rounds

Explore the complete funding history and valuation milestones for this company. Below you will find information about each funding round and key financial metrics that shaped the company's growth trajectory.

AI Medical Systems Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$120162016 cumulative: $0 • 2016 Founded: $02016 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold

AI Medical Systems Employees & Team Size

We do not have information about AI Medical Systems's team yet.

Customers

We do not have customer count information for AI Medical Systems yet.

Frequently Asked Questions about AI Medical Systems

What is AI Medical Systems's revenue?

GetLatka has not confirmed a public revenue figure for AI Medical Systems.

How much funding does AI Medical Systems have?

AI Medical Systems raised -.

How many employees does AI Medical Systems have?

AI Medical Systems has - employees.

Where is AI Medical Systems headquarters?

AI Medical Systems is headquartered in Zürich, Switzerland.

Compare AI Medical Systems to the industry

AI Medical Systems operates across multiple industries. Browse revenue, funding, and growth data for AI Medical Systems in each sector below.

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

AI Medical Systems Revenue, Valuation & Funding (2026)